Check · Hormones · DHEA In review

Does DHEA restore youthful hormones and slow aging in older adults?

Claim attributed to Anti-aging clinics and over-the-counter supplement sellers , DHEA is a steroid prohormone sold OTC in the US (exempted from scheduling) but prescription-only in most of the EU, UK, Canada and Australia. Sellers have a commercial tie and lean on the real fact that DHEAS falls with age to imply that topping it up reverses aging.

Verdict Unsupported

Evidence grade B Moderate certainty

DHEA reliably raises DHEAS and downstream sex steroids, but the best controlled trials find no meaningful effect on body composition, performance, cognition, mood, or any aging endpoint. The biomarker rises; the person does not measurably benefit.

It moves your hormone numbers on a lab report; it does not measurably move your body, your mood, or your clock.

The theory

What it’s supposed to target

DHEA to testosterone / estrogen
Adrenal “mother hormone”
Body composition + wellbeing (claimed)
Age-related decline

DHEA is an adrenal steroid, the most abundant in the bloodstream, that the body converts into testosterone and estrogen. Its levels peak in young adulthood and fall steeply with age. Because it sits upstream of the sex hormones, it gets marketed as a “mother hormone”: restore youthful DHEA, the theory goes, and you restore youthful muscle, libido, mood, and metabolism, slowing the hormonal side of aging.

The first step is real: DHEA supplements do raise DHEA-S and downstream sex-steroid levels. The functional payoff is where it fails. The decisive test, a two-year randomized trial in older adults (Nair 2006, NEJM), found no improvement in body composition, physical performance, insulin sensitivity, or quality of life, and meta-analyses since show at most a trivial effect on body fat. This is not merely untested but tested and largely negative: a plausible hormonal precursor that did not deliver the youth-restoring effects its marketing promises.

Mechanism is theory, not proof. A plausible pathway explains why something might work, not whether it does. The verdict rests on the evidence below, not the elegance of the theory.

The claim

What would have to be true

DHEAS must fall with age and that decline must cause age-related decline: the fall is real (holds), but causation is unproven.

Restoring DHEAS must restore function: tested and FAILED on muscle, fat, metabolism, cognition and mood.

Those functional gains must translate into slowed aging or longer life: never demonstrated, and the proxies are null.

The evidence

What the evidence actually shows

The biomarker moves, the body does not

The pivotal trial is Nair 2006 (NEJM), a 2-year, double-blind, placebo-controlled RCT in 144 elderly people with low DHEAS, funded by the NIH/NIA with no industry sponsor. DHEA raised DHEAS (median ~3.4 ug/mL in men, ~3.8 ug/mL in women) but had, in the authors' words, 'no physiologically relevant beneficial effects on body composition, physical performance, insulin sensitivity, or quality of life.' A later meta-analysis of 25 RCTs (1,353 men, Corona 2013) found only a small fat-mass reduction (SMD -0.35) that disappeared after adjusting for the rise in testosterone and estradiol, with no effect on lean mass, lipids, glycemia, bone or sexual function.

Cognition and mood: no convincing signal

A Cochrane systematic review (Grimley Evans 2006) concluded that 'what little evidence there is from controlled trials does not support a beneficial effect of DHEA supplementation on cognitive function' in non-demented middle-aged or older people, with no wellbeing or quality-of-life gain and a possible negative effect on visual memory after stress. The only thing DHEA dependably does is pharmacological: a dose-response meta-analysis (Zhu 2021, 21 arms, n=1,223) confirms it raises estradiol in women by about +7.02 pg/mL. Raising that number is not the same as restoring youth.

Evidence quality

Studies, graded, and who paid

DHEA raises blood DHEAS, testosterone and estradiol A High certainty

Confirmed by an NIH RCT and two meta-analyses; estradiol rise +7.02 pg/mL in women.

DHEA improves body composition or physical performance B Moderate certainty

2-year NEJM RCT null; any fat-mass signal vanishes after adjusting for sex steroids.

DHEA improves cognition, mood or wellbeing B Moderate certainty

Cochrane: controlled trials do not support a cognitive benefit; no wellbeing gain.

DHEA slows a validated aging process or extends lifespan C Low certainty

Never tested directly; every measurable proxy came back null, so unproven and unpromising.

Cited studies with type, size, funding/conflicts, and limitations.
#	Study	Type	Size	Funding / COI	Key limitations
1	Nair 2006, NEJM, 2-year RCT in elderly with low DHEAS	Randomized double-blind placebo-controlled trial (2 years)	n=144 (87 men, 57 women)	Independent NIH/NIA grants (P01 AG14283, M01 RR00585); no industry sponsor.	Enrolled low-DHEAS people most likely to benefit, yet functional outcomes were null.
2	Corona 2013, JCEM, meta-analysis in elderly men	Meta-analysis of RCTs	25 trials, n=1,353, mean 36 weeks	Funding unknown Funding/COI not disclosed; academic endocrinology authors.	Small fat-mass effect vanished after adjusting for sex steroids; mostly short trials.
3	Grimley Evans 2006, Cochrane, DHEA for cognition	Cochrane systematic review of RCTs	Pooled small RCTs (~46-75 each)	Independent Cochrane Collaboration; no commercial sponsor.	Few trials and limited data, but consistently null on cognition and wellbeing.
4	Zhu 2021, Steroids, estradiol dose-response in women	Dose-response meta-analysis of RCTs	21 arms, n=1,223 women	Funding unknown Funding/COI not disclosed; supports only the biomarker point.	Establishes estradiol rise, not any functional or anti-aging benefit.

This is the classic true-but-misleading biomarker pitch: a real lab change (DHEAS, testosterone, estradiol go up) is sold as functional restoration the trials never deliver.

See who funded the studies behind every Caveat check

Stay neutral

Unproven ≠ disproven

No RCT has measured lifespan, mortality, or a validated aging clock under DHEA, so the literal 'slows aging' claim is untested rather than directly disproven.

But every measurable proxy that aging claims rest on, muscle, fat, metabolism, cognition and mood, was tested and came back null or trivial.

The gap

Where claim and evidence diverge

The one genuine evidence gap, true lifespan or mortality endpoints, is unlikely to ever be funded for a cheap, unpatentable OTC molecule.

Meanwhile US OTC status removes any requirement to prove efficacy, so marketing claims run far ahead of the trial record.

Follow the funding

The money trail

DHEA is unpatentable and sold OTC in the US, so no manufacturer funds the large, long trials that could test anti-aging endpoints; the rigorous evidence that exists is independent and NIH-funded, and it is negative.

The favorable spin lives in seller blogs and clinic marketing built on association data, not in the controlled-trial literature.

Bottom line

The honest read

DHEA does raise your hormone numbers, but in the best trials that is all it does: no proven gain in body, performance, mood, or aging for healthy older adults.

Replacement in diagnosed adrenal insufficiency is a separate question; this verdict is about anti-aging use.

Falsifiable

What would change this verdict

A large, independent, long-duration RCT showing DHEA improves a hard functional endpoint (strength, frailty, disability) beyond what its sex-steroid rise explains.

Evidence that DHEA reduces mortality or moves a validated aging biomarker versus placebo.

Receipts

Sources

Common questions